Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
02/2011
02/01/2011US7880005 Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid
02/01/2011US7879887 such as 2-(4-chloro-3-hydroxyphenylamino)-N-(6H-pyrazolo[4',3':3,4]benzo[1,2-d]thiazol-2-yl)-acetamide, having antitumor activity, particularly dual inhibitory activity on Aurora kinase and cyclin-dependent kinase (CDK), and are useful for cell proliferative diseases such as cancer
02/01/2011US7879886 such as N-benzyl-N-hydroxy-2-(3-hydoxypyridin-2-ene)-1,3-thiazolidine-4-carboxamide, used for reducing the population of Plasmodium in a human infested with Plasmodium protozoans and suffering from malaria
01/2011
01/27/2011WO2011010715A1 Pr-set7 inhibitor
01/27/2011WO2011010013A1 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway
01/27/2011US20110021557 Deuterium-enriched pyridinonecarboxamides and derivatives
01/27/2011US20110021494 Novel tetrahydro-fused pyridines as histone deacetylase inhibitors
01/27/2011CA2769474A1 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway
01/26/2011EP2276769A1 New peptidomimetic compounds
01/26/2011EP2276767A1 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
01/26/2011EP2276757A2 Macrocyclic compounds and methods of treatment
01/26/2011EP2276731A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
01/26/2011EP2155740B1 Hetarylanilines as modulators for amyloid beta
01/26/2011EP2086537B1 Imidazo[2,1-b]thiazoles and their use as pharmaceuticals
01/26/2011EP2034834B1 Prodrugs of 5-amino-3-(3'-deoxy-beta-d-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione
01/26/2011CN101959877A Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
01/25/2011US7875626 Therapeutic agents
01/25/2011CA2535370C Isothiazoloquinolones and related compounds as anti-infective agents
01/25/2011CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives
01/20/2011WO2011008487A1 Pyrimidinones as pi3k inhibitors
01/20/2011WO2010003475A8 Novel pyrrolidone derivatives for use as metap-2 inhibitors
01/20/2011US20110015201 Hedgehog pathway antagonists and methods of use
01/20/2011US20110014250 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages
01/20/2011CA2766100A1 Pyrimidinones as pi3k inhibitors
01/19/2011EP2094685B1 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors
01/19/2011CN101952259A Benzodiazepine compound and pharmaceutical composition
01/18/2011US7872139 Heteroaryl-ureas and their use as glucokinase activators
01/13/2011WO2011005738A1 Bace inhibitors
01/13/2011US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
01/13/2011US20110009624 Benzimidazole compounds having gastric acid secretion inhibitory action
01/13/2011US20110009461 2-aza-bicyclo[3.3.0]octane derivatives
01/13/2011US20110009401 2-aza-bicyclo[2.2.1]heptane derivatives
01/13/2011US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
01/13/2011US20110009395 Bace inhibitors
01/13/2011US20110009394 Tricyclic nitrogen compounds and their use as antibacterial agents
01/13/2011US20110009389 Imidazole derivative, their production and use
01/13/2011US20110009385 Compounds
01/13/2011US20110009381 Solubilized thiazolopyridines
01/13/2011US20110009378 Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
01/13/2011US20110008288 Hepatitis c virus inhibitors
01/13/2011US20110006287 Polymers with tunable band gaps for photonic and electronic applications
01/13/2011CA2764429A1 Condensed aminodihydrothiazine derivatives as bace inhibitors
01/12/2011EP2271625A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
01/12/2011CN101945867A Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
01/12/2011CN101941984A 2,1,3-thiazole and naphthalimide compound and application thereof in tumor cell
01/11/2011US7868204 Inhibitors of histone deacetylase
01/11/2011US7868001 such as 2-(3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)imidazo[1,2-b]pyridazine, used for decreasing the levels of tumor necrosis factors or interleukines; treatment of inflammation, autoimmune diseases, diabetes, atherosclerosis and cancer
01/11/2011US7868000 Aspartyl protease inhibitors
01/11/2011CA2430124C Lactam compounds and pharmaceutical use thereof
01/06/2011WO2011000855A1 2-carboxamide cycloamino ureas useful as pi3k inhibitors
01/06/2011WO2011000455A1 Materials for organic electroluminescence devices
01/06/2011WO2010130934A3 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole derivatives, preparation thereof, and therapeutic use thereof
01/06/2011US20110003840 Pyridoindolobenzox-and thiazepine derivatives and uses thereof
01/06/2011US20110003807 Thiazole derivatives
01/06/2011US20110003806 Heteroaryls and uses thereof
01/06/2011US20110003786 2-Carboxamide Cycloamino Ureas
01/06/2011CA2766853A1 2-carboxamide cycloamino ureas useful as pi3k inhibitors
01/05/2011EP2268636A1 Gamma secretase modulators
01/05/2011CN101939315A Gamma secretase modulators
01/05/2011CN101939302A Mesoionic pesticides
01/05/2011CN101089000B Spiro piperazine quaternary ammonium salt compound and its preparation method and application
01/04/2011US7863306 Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
01/04/2011US7863288 protein kinase modulators such as Propane-1-sulfonic acid [2,4-difluoro-3-(5-ethoxy-1H-pyrrolo[1,3-b]pyridine-3-carbonyl)-phenyl]-amide, used to regulate signal transduction cascades, involved in the control of physiological functions including cellular growth and proliferation; anticarcinogenic agents
12/2010
12/30/2010US20100331310 Bicycloamine derivatives
12/30/2010US20100331283 Mitotic kinesin inhibitors and methods of use thereof
12/30/2010US20100330199 Isothiazole-pyridine derivates as modulators of hif (hypoxia inducible factor) activity
12/30/2010US20100330021 Substituted (thiazol-2-yl)-amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
12/29/2010EP2266992A2 Process for producing thiazole derivative
12/29/2010EP2266991A2 Process for producing thiazole derivative
12/29/2010EP2266990A1 3-PHENYLPYRAZOLOÝ5,1-b¨THIAZOLE COMPOUND
12/29/2010EP2266981A2 Benzothiazole compounds useful as kinase inhibitors
12/29/2010EP2265270A1 2-aminopyridine kinase inhibitors
12/29/2010EP2185512B1 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
12/29/2010EP1560827B1 Anti-infective agents
12/29/2010CN1926132B Pyrazole compounds useful as protein kinase inhibitors
12/29/2010CN1902196B Thiazole derivative
12/29/2010CN1878778B Process for producing thiazole derivative
12/29/2010CN101932587A Thiazolopyrimidine p13k inhibitor compounds and methods of use
12/29/2010CA2765819A1 Heterocyclic compounds and their uses as inhibitors of p13 k activity
12/23/2010WO2010147169A1 Pharmaceutical composition having improved solubility
12/23/2010WO2010103130A3 Thiazolopyrimidine modulators as immunosuppressive agents
12/23/2010WO2010084508A3 Process for the preparation of type i, type ii and type iii crystalline prulifloxacin
12/23/2010WO2010054278A3 Compounds for the treatment of inflammatory disorders
12/23/2010WO2010010435A3 Fused oxazole and thiazole derivatives as trpms modulators
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324030 5-Quinoline derivatives having an anti-bacterial activity
12/23/2010US20100323889 Herbicidal compounds
12/23/2010US20100322901 5, 6-ring annulated indole derivatives and use thereof
12/23/2010CA2765522A1 Solid pharmaceutical composition of edoxaban having improved solubility
12/22/2010EP2264037A1 Vasopressin v1a antagonists
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP1805156B1 Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
12/22/2010CN101925606A Compounds comprising a cyclobutoxy group
12/21/2010US7855297 Amide derivatives and medicinal use thereof
12/16/2010WO2010142027A1 Guanine riboswitch binding compounds and their use as antibiotics
12/16/2010US20100317850 Condensed aminodihydrothiazine derivative
12/16/2010US20100317655 Sulfonamide inhibitors of carbonic anhydrase
12/16/2010CA2778931A1 Guanine riboswitch binding compounds and their use as antibiotics
12/15/2010EP2261226A1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
12/15/2010EP1848723B1 New isothiazoloquinolones and related compounds as anti-infective agents
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 152